This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Merck KGaA

Drug Names(s): FC EPO

Description: FC EPO is a fusion protein (Fc-EPO) comprising a Fc portion of an Ig molecule which is covalently fused to an erythropoietin molecule (EPO). The fused protein has a longer serum half-life and increased potency compared to erythropoeitin (this may be through amino acid changes that reduces transferring the molecule into the cell by the epo receptor [endocytosis]).


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug